K122688 is an FDA 510(k) clearance for the NOVA MAX MINI BLOOD GLUCOSE AND B-KETONE MONITOR. This device is classified as a Glucose Dehydrogenase, Glucose (Class II - Special Controls, product code LFR).
Submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on April 4, 2013, 212 days after receiving the submission on September 4, 2012.
This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1345.
| 510(k) Number | K122688 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | September 04, 2012 |
| Decision Date | April 04, 2013 |
| Days to Decision | 212 days |
| Submission Type | Traditional |
| Review Panel | Chemistry (CH) |
| Summary | Summary PDF |
| Product Code | LFR — Glucose Dehydrogenase, Glucose |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.1345 |